ArticleInternational journal of legal medicine2026
Gender differences in sociodemographic, clinical characteristics, and psychopharmacological treatments among forensic ınpatients with serious mental ıllness in Türkiye.
Article in International journal of legal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGender differences in psychiatric symptoms and pharmacological treatment are well-documented in general psychiatry but remain understudied in forensic psychiatric populations. This study aimed to explore gender-based differences in sociodemographic, clinical, criminal, biochemical, and pharmacological characteristics among forensic inpatients with serious mental illness (SMI).
methodsA total of 100 patients (59 men, 41 women) with SMI who were admitted to the forensic psychiatry department by court order were included in a two-time-point observational cohort study with assessments at admission (T1) and discharge (T2). Sociodemographic and clinical traits, criminal data, psychopathological features, blood test results, medication dosages (including antipsychotic equivalent doses calculated using four methods), and treatment side effects were evaluated (T1 and T2) and then compared between genders.
resultsNo gender differences were observed in clinical symptom severity, functional level, side-effect profile, hospitalization duration, or treatment type (monotherapy vs polypharmacy; LAI use; adjunctive medications such as benzodiazepines, mood stabilizers, and anticholinergics). Men experienced more hospital admissions and guardianship cases. The age at first offense was younger among men, but the rate of violent crime was higher among women. Men were prescribed notably higher doses of antipsychotics, even when accounting for confounders (according to the WHO-defined daily dose and the Maudsley 2025 equivalent dose table). Furthermore, men were more likely to be using high doses of antipsychotics.
conclusionsThe study provides new data from an underrepresented population. It highlights gender differences in forensic psychiatry, especially in treatment dosages. Clinicians view male patients with SMI as more aggressive, impulsive, or more likely to reoffend. More personalized and gender-sensitive prescribing practices may be necessary in forensic psychiatry settings.
Indexed as
Identifiers
42414652What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.